# Layer 6 is a hub for cholinergic modulation in the mouse auditory cortex

**Authors:** Lucas G Vattino, Kameron K Clayton, Troy A Hackett, Daniel B Polley, Anne E Takesian

PMC · DOI: 10.1093/cercor/bhaf338 · 2026-01-22

## TL;DR

The study shows that layer 6 pyramidal neurons in the mouse auditory cortex are a key hub for cholinergic signaling, working alongside layer 1 inhibitory neurons to modulate cortical circuits.

## Contribution

The paper identifies layer 6 pyramidal neurons as a novel hub for cholinergic modulation in the auditory cortex, revealing distinct receptor mechanisms and circuit roles.

## Key findings

- Layer 6 pyramidal neurons are enriched in nicotinic and muscarinic ACh receptor transcripts.
- BFCN axon activation elicits fast nAChR-mediated excitation and slower mAChR-mediated inhibition in layer 6.
- Layer 6 and layer 1 neurons represent two major hubs for cholinergic modulation in the auditory cortex.

## Abstract

Basal forebrain cholinergic neurons (BFCNs) densely innervate auditory cortex (ACtx), conveying signals linked to internal brain states and external sensory cues. Acetylcholine (ACh) is known to rapidly modulate cortical circuits through nicotinic ACh receptor (nAChR)-mediated activation of layer 1 inhibitory neurons (L1-INs). However, BFCN terminals are also abundant in deeper layers, where their functional impact has received less attention. Using multi-plex in situ labeling across cortical layers and cell types, we found that layer 6 pyramidal neurons (L6-PNs) are highly enriched in diverse transcripts for nAChR subunits and muscarinic ACh receptors (mAChRs). In vivo optogenetic activation of BFCN axons revealed persistent modulation of regular spiking units in L2-6 but a rapid phasic activation only in L6. In acute slices, optogenetic activation of BFCN axons elicited fast nAChR-mediated excitatory post-synaptic potentials in L6-PNs, comparable to responses in L1-INs, and slower mAChR-mediated inhibitory responses. These findings identify L1-INs and excitatory L6-PNs as two major hubs for BFCN modulation of cortical circuits. By recruiting distinct receptor mechanisms and circuit motifs in L1 and L6, BFCNs may engage parallel pathways of cholinergic control that couple fast, transient modulation with slower, sustained regulation to shape cortical perception and plasticity.

## Linked entities

- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Slc32a1 (solute carrier family 32 (GABA vesicular transporter), member 1) [NCBI Gene 22348] {aka VGAT, Viaat}, Pvalb (parvalbumin) [NCBI Gene 19293] {aka PV, Parv, Pva}, Calca (calcitonin/calcitonin-related polypeptide, alpha) [NCBI Gene 12310] {aka CA, CGRP-1, CGRP1, Calc, Calc1, Cgrp}, Ugt1a2 (UDP glucuronosyltransferase 1 family, polypeptide A2) [NCBI Gene 396527] {aka UDPGT 1-2, Udpgt, Ugt1}, Chat (choline O-acetyltransferase) [NCBI Gene 12647] {aka B230380D24Rik, CHOACTase}, Slc6a12 (solute carrier family 6 member 12) [NCBI Gene 50676] {aka BGT1, Gat1, RNU28927, VGAT}, Chrna7 (cholinergic receptor, nicotinic, alpha polypeptide 7) [NCBI Gene 11441] {aka Acra7, alpha7, nAChR7, nAchR}, Slc17a7 (solute carrier family 17 member 7) [NCBI Gene 116638] {aka BNPI, Vglut1}, Pcyt1b (phosphate cytidylyltransferase 1B, choline) [NCBI Gene 286936] {aka CCT-beta, CTB, Cctbeta}, Eif1a (eukaryotic translation initiation factor 1A) [NCBI Gene 13664] {aka Ef1a, Eftu, Eif4c, eIF-1A, eIF-4C}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Cdh23 (cadherin related 23 (otocadherin)) [NCBI Gene 22295] {aka 4930542A03Rik, USH1D, ahl, ahl1, bob, bus}, Slc17a7 (solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7) [NCBI Gene 72961] {aka 2900052E22Rik, Vglut1}, Chrnb1 (cholinergic receptor nicotinic beta 1 subunit) [NCBI Gene 24261] {aka Acrb, RNACRB1, nAChR}, Itga7 (integrin alpha 7) [NCBI Gene 16404] {aka [a]7, alpha7}
- **Diseases:** CSD (MESH:D001851)
- **Chemicals:** Meloxicam (MESH:D000077239), KOH (MESH:C029943), glucose (MESH:D005947), DAPI (MESH:C007293), ACh (MESH:D000109), MgCl2 (MESH:D015636), AMPA and NMDA receptor antagonists (-), AgCl (MESH:C037548), ACD (MESH:C002113), Alexa Fluor 647 (MESH:C569686), C&amp;B metabond (MESH:C049495), K+ (MESH:D011188), NaHCO3 (MESH:D017693), ethanol (MESH:D000431), CaCl2 (MESH:D002122), paraformaldehyde (MESH:C003043), methyllycaconitine (MESH:C054634), phosphate (MESH:D010710), sucrose (MESH:D013395), EGTA (MESH:D004533), atropine (MESH:D001285), Mg-ATP (MESH:D000255), Buprenex (MESH:D002047), DNQX (MESH:C056723), CO2 (MESH:D002245), isoflurane (MESH:D007530), titanium (MESH:D014025), NaCl (MESH:D012965), KCl (MESH:D011189), HEPES (MESH:D006531)
- **Species:** adeno-associated virus 2 (no rank) [taxon 10804], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090], Rodentia (rodent, order) [taxon 9989]
- **Cell lines:** S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232)

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12825313/full.md

---
Source: https://tomesphere.com/paper/PMC12825313